Tuesday, June 21, 2011 2:47:12 PM
You appear to be remarkably incapable of or resistant to making any sort of distinction between companies. If you would take a look at the basic fundamentals of what KBLB is and what it's doing you would see a huge difference between it and the overwhelming majority of other penny stocks:
A market ready product already (Monster Silk).
A company right now testing another KBLB product for suitability for inclusion in its product line.
Several additional products under development with strong evidence of progress (The Gen2 worms being genticaly modified right now with zinc fingers (we could get news on that literally at any moment now).
Then there are the Gen3 products and the platform worm.
KBLB has made a major deal with SIAL, one of the largest and most respected companies in biotechnogy and most of what SIAL is receiving is in the form of royalties (the $70,000 fee is peanuts compared to the potential royalties) so SIAL most definately has a lot of "skin in the game". Not only that but SIAL is highlighting KBLB as the "poster child" for its new custom zinc finger service.
Yet you apparently see no difference between KBLB and other penny stocks. If you want to just trade and consider all stocks equal, that's your business. But it is highly unrealistic to expect all others to take the same approach.
A market ready product already (Monster Silk).
A company right now testing another KBLB product for suitability for inclusion in its product line.
Several additional products under development with strong evidence of progress (The Gen2 worms being genticaly modified right now with zinc fingers (we could get news on that literally at any moment now).
Then there are the Gen3 products and the platform worm.
KBLB has made a major deal with SIAL, one of the largest and most respected companies in biotechnogy and most of what SIAL is receiving is in the form of royalties (the $70,000 fee is peanuts compared to the potential royalties) so SIAL most definately has a lot of "skin in the game". Not only that but SIAL is highlighting KBLB as the "poster child" for its new custom zinc finger service.
Yet you apparently see no difference between KBLB and other penny stocks. If you want to just trade and consider all stocks equal, that's your business. But it is highly unrealistic to expect all others to take the same approach.
Recent KBLB News
- Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations • GlobeNewswire Inc. • 05/26/2026 11:35:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:20 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:19 PM
- Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform • GlobeNewswire Inc. • 05/20/2026 11:35:00 AM
- Immortalized Silk Gland Cell Line Breakthrough Expands Kraig Biocraft’s Biotech Ambitions (KBLB) • IH Market News • 05/18/2026 03:12:33 PM
- Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications • GlobeNewswire Inc. • 05/18/2026 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:31:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/14/2026 12:14:08 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/14/2026 04:15:05 AM
- The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer • GlobeNewswire Inc. • 05/13/2026 01:05:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/11/2026 08:30:47 PM
- Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up • GlobeNewswire Inc. • 05/11/2026 11:05:00 AM
- Kraig Biocraft Laboratories Positions Itself as a Front-Runner in Spider Silk Race • GlobeNewswire Inc. • 05/07/2026 01:05:00 PM
- Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output • GlobeNewswire Inc. • 05/04/2026 11:05:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/30/2026 09:07:15 PM
- Kraig Biocraft (KBLB) Spider Silk Production Milestone Signals Progress Toward Commercialization • IH Market News • 04/30/2026 02:54:26 PM
- Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations • GlobeNewswire Inc. • 04/30/2026 01:20:00 PM
- Kraig Biocraft (USOTC:KBLB) Hits 50% Production Milestone — Spider Silk Push Moves Closer to Commercial Scale • IH Market News • 04/28/2026 01:51:39 PM
- Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk • GlobeNewswire Inc. • 04/28/2026 11:05:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
